Siloton specialises in miniaturised optical technology for medical imaging, using photonic chips and OCT to detect and monitor major diseases like macular degeneration, glaucoma, diabetes, MS, and certain cancers.
At Siloton, we are experts in miniaturising optics for medical applications, using photonic chip technology.
Trailblazing eye imaging technologies
Our products are designed around an imaging technique called Optical Coherence Tomography (OCT), which is widely used for detecting and monitoring some of the world’s most prevalent diseases, including age-related macular degeneration and glaucoma.
It can also pick up on conditions such as multiple sclerosis, diabetes, and certain types of cancers.
Are you developing a new OCT product that could benefit from the advantages photonic chips have to offer?
Siloton’s OCT-Chip Development Kits allow you to rapidly evaluate the technology and de-risk its adoption. Leasing a development kit also gives you priority access to our next generation of device.
Looking for a slightly different wavelength or additional functionality? Our Feasibility & Customisation packages tweak our off-the-shelf products to work for you.
Coming Soon – Siloton’s very own Ophthalmic OCT System, powered by the same technology as our development kits.
As featured in:
AWARD
The Clifford Paterson Medal & Prize
Awarded to Dr Alasdair Price and Dr Euan Allen by the Institute of Physics “for developing and commercialising a world-leading integrated photonics platform for optical coherence tomography, and designing a personal eye scanner around it to prevent sight loss from age-related macular degeneration.”
AWARD
Institute of Physics Business Start-Up Award
Awarded to Siloton “for the development of a personal optical coherence tomography system, capable of reducing sight loss caused by age-related macular degeneration.”